Shanghai Pharmaceuticals Holding Co., Ltd
601607
Rank in Stocks
#2387
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Share Price
$2.43
Market Cap
$8.09B
Change (1 day)
-1.16%
Change (1 year)
-5.94%
Country
CN
Trade Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Category
Healthcare
Revenue for Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Revenue in Oct 2026 TTM: 0
According to Shanghai Pharmaceuticals Holding Co., Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shanghai Pharmaceuticals Holding Co., Ltd from 2001 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2025 | $40.53B | 7.48% |
| 2024 | $37.71B | 2.55% |
| 2023 | $36.77B | 9.34% |
| 2022 | $33.63B | -0.96% |
| 2021 | $33.96B | 15.59% |
| 2020 | $29.38B | 9.64% |
| 2019 | $26.79B | 15.85% |
| 2018 | $23.13B | 15.00% |
| 2017 | $20.11B | 15.62% |
| 2016 | $17.39B | 7.05% |
| 2015 | $16.25B | 8.92% |
| 2014 | $14.92B | 15.68% |
| 2013 | $12.90B | 18.12% |
| 2012 | $10.92B | 25.36% |
| 2011 | $8.71B | 53.65% |
| 2010 | $5.67B | 97.75% |
| 2009 | $2.87B | 18.19% |
| 2008 | $2.43B | 27.21% |
| 2007 | $1.91B | 30.42% |
| 2006 | $1.46B | 10.27% |
| 2005 | $1.33B | 1.43% |
| 2004 | $1.31B | 10.52% |
| 2003 | $1.18B | 35.26% |
| 2002 | $874.21M | 39.06% |
| 2001 | $628.65M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $410.98B | - |
US
|
|
| - | - |
US
|
|
| $254.25B | - |
US
|
|
| - | - |
US
|
|
| $7.64B | - |
AU
|
